RESEARCH

Pacific's scientific innovations are defined and supported by an international / professional R&D staff of approximately 200 professionals. Our discovery efforts focused on antiviral development have resulted in significant accomplishments since 2000. We have advanced two compounds (viramidine and remofovir) into clinical development and created significant value to our Company. Over the past four years, our Company has invested significant capital and resources to modernize our laboratories and establish a world-class state-of-the-art R&D capability. A cross functional and fully integrated Drug Discovery infrastructure has been established among multi-disciplinary scientists to ensure that relevant targets are selected and tractable drug candidates with sound mechanisms of action are moved rapidly through the pipeline. We have created a multi-parametric system to evaluate efficacy, safety, drug metabolism and compound-enabling formulation and to enhance drug-like features.